RIGEL PHARMACEUTICALS, INC. (RIGL) Total assets 2016–2025
RIGEL PHARMACEUTICALS, INC. (RIGL) total assets at each fiscal year-end, per SEC filings.
$513.6MFY2025 · since FY2016: $78.1M → $513.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $513.6M | +213.2% |
| FY2024 | $164.0M | +39.9% |
| FY2023 | $117.2M | -12.7% |
| FY2022 | $134.3M | -19.8% |
| FY2021 | $167.3M | +51.6% |
| FY2020 | $110.4M | -25.2% |
| FY2019 | $147.6M | +6.1% |
| FY2018 | $139.1M | +16.8% |
| FY2017 | $119.1M | +52.4% |
| FY2016 | $78.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More RIGL financial trends
RIGL RevenueRIGL Net incomeRIGL Net marginRIGL Gross profitRIGL Gross marginRIGL Operating incomeRIGL Operating marginRIGL Operating cash flowRIGL Free cash flowRIGL Capital expendituresRIGL Return on equityRIGL Stock buybacksRIGL Dividends paidRIGL Total liabilitiesRIGL Shareholders’ equityRIGL overview →